Navigation Links
Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
Date:7/21/2011

ng to patients appropriate for the medications.  All stakeholders can enroll in the system any time beginning in September 2011.  There will be a transition period of about six months following launch of the REMS after which no prescription may be dispensed unless the prescriber and pharmacy are enrolled.    

Cephalon will provide regular updates to FDA regarding the effectiveness of the REMS.  Based on these evaluations, Cephalon plans to open discussions with FDA regarding the Company's pending supplemental New Drug Application for FENTORA as a treatment for opioid-tolerant patients with non-cancer breakthrough pain.

Important Safety Information

WARNING: IMPORTANCE OF PROPER PATIENT SELECTION, DOSING, and POTENTIAL FOR ABUSE

Reports of serious adverse events, including deaths in patients treated with ACTIQ® have been reported.  Deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients) and/or improper dosing. The substitution of ACTIQ for any other fentanyl product may result in fatal overdose.

ACTIQ is indicated only for the management of breakthrough cancer pain in patients with malignancies who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain. Patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine daily, at least 25 mcg of transdermal fentanyl/hour, at least 30 mg of oral oxycodone daily, at least 8 mg oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

ACTIQ is not indicated for use in opioid non-tolerant patients including those with only as needed (PRN) prior exposure.

Life-threatening respiratory depression could occur at any dose in opioid non-tolerant pa
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cephalon Shareholders Approve Acquisition by Teva
2. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
3. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
4. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
5. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
6. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
7. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
8. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
9. Cephalon Wins FENTORA Patent Suit Against Watson
10. Cephalon Announces Definitive Agreement to Acquire Gemin X
11. Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
(Date:8/29/2014)... Research and Markets  has announced the addition of ... 2014-2018" report to their offering. ... connect, support, or surround bones. There are several types ... fascia, and other fibrous tissues. Repetitive use, accidents, injuries, ... in wear and tear in these tissues. Orthopedic soft ...
(Date:8/28/2014)... 28, 2014  Rigrodsky & Long, P.A.: , ... (NYSE: LCI )? , Did you purchase your ... July 16, 2014, inclusive? , Did you lose money ... you want to discuss your rights? ... Attorney, Timothy J. MacFall , announces that a complaint has ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
(Date:8/29/2014)... Highly regarded audiologist , Dr. Mary Ann Larkin has ... four reports are titled:, , Revealing the Truth ... , The Top 5 Things You Should Know Before ... in Children , Dr. Mary Anne Larkin choose to ... confusion and misinformation about each them. The reports are available ...
(Date:8/29/2014)... La Mirada, CA (PRWEB) August 29, 2014 ... multidisciplinary healthcare organizations, acquired a new medical center from LAXMed. ... LAX airport and less than 2 miles west of the ... Healthpointe center within Southern California. The new LAX center is ... CA 90045. , The new Healthpointe LAX ...
(Date:8/29/2014)... August 29, 2014 The family of ... a series of dialysis treatments has filed a GranuFlo ... was the result of Fresenius Medical Care’s GranuFlo and ... lawsuit, which was file d in Alameda County Superior ... of the products resulted in metabolic alkalosis, a ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... “The Safety Chick” who profiled a handful of ... Earphones from Etymotic Research. This year, many schools ... and Etymotic, an innovator of hearing wellness solutions, ... Their ETY•Kids Safe-Listening Earphones, offered in yellow, pink ...
(Date:8/29/2014)... Steven Reinberg ... News) -- The vast majority of American babies are ... serious illnesses, federal health officials said Thursday. More ... that prevent measles, mumps, and rubella (MMR); polio; hepatitis ... for Disease Control and Prevention. "Nationally, vaccination among ...
Breaking Medicine News(10 mins):Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
... Meeting of the European Society of Cardiology Council on ... with the Irish Nurses Cardiovascular Association (INCA), is being ... 24-25 April. , The meeting - considered by ... and allied health professionals - will show case the ...
... American Heart Association has partnered with Wiley-Blackwell to ... American Heart Association Clinical Series, designed to help ... patient care. , Each hardcover volume focuses ... on their areas of individual expertise under the ...
... YARDLEY, Pa., April 8 Core Essence Orthopaedics, ... tissue and skeletal repair of the extremities, today ... from the Food and Drug Administration (FDA) for ... in minimally invasive, arthroscopic surgery. SECURUS provides increased ...
... Educational Software (AES), a leading provider of software for ... to announce the addition of Susan DuRant to the ... is the parent of a child with autism and ... be a great asset to our company and help ...
... sales of OTC drugs grew by 2.4% from $17.8 ... to the latest research in Nonprescription Drugs USA ... and research firm Kline & Company.Private-label OTC medicines were ... antacids and allergy medicines posted the highest growth last ...
... A Florida judge has ruled that a state ... bona fide professional organizations is unconstitutional and violates the ... The American Academy of Implant Dentistry (AAID) said today ... qualifications and experience of dentists who perform implant procedures ...
Cached Medicine News:Health News:Telemonitoring changes the working practice of cardiac nurses 2Health News:Telemonitoring changes the working practice of cardiac nurses 3Health News:Telemonitoring changes the working practice of cardiac nurses 4Health News:Telemonitoring changes the working practice of cardiac nurses 5Health News:Telemonitoring changes the working practice of cardiac nurses 6Health News:Wiley-Blackwell and the American Heart Association present new book series 2Health News:Core Essence Receives FDA Approval for SECURUS(TM), an Innovative Knotless Suture Anchor System 2Health News:Core Essence Receives FDA Approval for SECURUS(TM), an Innovative Knotless Suture Anchor System 3Health News:Autism Software Developer Announces Hiring of Susan DuRant as Director of Education 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 3Health News:AAID Hails Florida Court Verdict Allowing Advertising of Bona Fide Dental Credentials 2
Sprint Quattro Secure™ is a Steroid-Eluting, True Bipolar, Active Fixation ICD Lead....
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
The TVL-ADX lead is a thin, high-performing defibrillation lead that offers a true bipolar configuration designed for smarter sensing and low defibrillation threshold for greater patient safety margi...
... SPL defibrillator lead features a ... the flexibility and maneuverability of ... the physician who prefers a ... the SPL lead also promotes ...
Medicine Products: